BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1151 related articles for article (PubMed ID: 17440684)

  • 1. Hypoxia in cancer: significance and impact on clinical outcome.
    Vaupel P; Mayer A
    Cancer Metastasis Rev; 2007 Jun; 26(2):225-39. PubMed ID: 17440684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
    Vordermark D; Brown JM
    Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous hypoxia markers in locally advanced cancers of the uterine cervix: reality or wishful thinking?
    Mayer A; Höckel M; Vaupel P
    Strahlenther Onkol; 2006 Sep; 182(9):501-10. PubMed ID: 16944371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia in head and neck cancer: how much, how important?
    Janssen HL; Haustermans KM; Balm AJ; Begg AC
    Head Neck; 2005 Jul; 27(7):622-38. PubMed ID: 15952198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.
    Dellas K; Bache M; Pigorsch SU; Taubert H; Kappler M; Holzapfel D; Zorn E; Holzhausen HJ; Haensgen G
    Strahlenther Onkol; 2008 Mar; 184(3):169-74. PubMed ID: 18330514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hemoglobin levels on tumor oxygenation: the higher, the better?
    Vaupel P; Mayer A; Höckel M
    Strahlenther Onkol; 2006 Feb; 182(2):63-71. PubMed ID: 16447012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?
    Harrison L; Blackwell K
    Oncologist; 2004; 9 Suppl 5():31-40. PubMed ID: 15591420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia.
    Kizaka-Kondoh S; Konse-Nagasawa H
    Cancer Sci; 2009 Aug; 100(8):1366-73. PubMed ID: 19459851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.
    Ebbesen P; Pettersen EO; Gorr TA; Jobst G; Williams K; Kieninger J; Wenger RH; Pastorekova S; Dubois L; Lambin P; Wouters BG; Van Den Beucken T; Supuran CT; Poellinger L; Ratcliffe P; Kanopka A; Görlach A; Gasmann M; Harris AL; Maxwell P; Scozzafava A
    J Enzyme Inhib Med Chem; 2009 Apr; 24 Suppl 1():1-39. PubMed ID: 19330638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of apoptotic protease activating factor-1 expression and resistance to hypoxia-induced apoptosis in cervical cancer.
    Leo C; Horn LC; Rauscher C; Hentschel B; Richter CE; Schütz A; Leo CP; Höckel M
    Clin Cancer Res; 2007 Feb; 13(4):1149-53. PubMed ID: 17317823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic potential of the pre-therapeutic tumor oxygenation status.
    Vaupel P
    Adv Exp Med Biol; 2009; 645():241-6. PubMed ID: 19227477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review.
    Hoogsteen IJ; Marres HA; Bussink J; van der Kogel AJ; Kaanders JH
    Head Neck; 2007 Jun; 29(6):591-604. PubMed ID: 17252597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygenation status of gynecologic tumors: what is the optimal hemoglobin level?
    Vaupel P; Thews O; Mayer A; Höckel S; Höckel M
    Strahlenther Onkol; 2002 Dec; 178(12):727-31. PubMed ID: 12491062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of tumor tissue oxygenation: agents, methods and clinical significance.
    Pauwels EK; Mariani G
    Drug News Perspect; 2007 Dec; 20(10):619-26. PubMed ID: 18301796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor oxygenation status as a prognostic marker.
    Menon C; Fraker DL
    Cancer Lett; 2005 Apr; 221(2):225-35. PubMed ID: 15808408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EF5 binding and clinical outcome in human soft tissue sarcomas.
    Evans SM; Fraker D; Hahn SM; Gleason K; Jenkins WT; Jenkins K; Hwang WT; Zhang P; Mick R; Koch CJ
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):922-7. PubMed ID: 16458778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microregional expression of glucose transporter-1 and oxygenation status: lack of correlation in locally advanced cervical cancers.
    Mayer A; Höckel M; Wree A; Vaupel P
    Clin Cancer Res; 2005 Apr; 11(7):2768-73. PubMed ID: 15814659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis.
    Sun HC; Qiu ZJ; Liu J; Sun J; Jiang T; Huang KJ; Yao M; Huang C
    Int J Oncol; 2007 Jun; 30(6):1359-67. PubMed ID: 17487356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.
    Grigiene R; Valuckas KP; Aleknavicius E; Kurtinaitis J; Letautiene SR
    BMC Cancer; 2007 Dec; 7():234. PubMed ID: 18154683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical study of hypoxia using endogenous hypoxic markers and polarographic oxygen electrodes.
    Sakata K; Someya M; Nagakura H; Nakata K; Oouchi A; Hareyama M; Satoh M
    Strahlenther Onkol; 2006 Sep; 182(9):511-7. PubMed ID: 16944372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.